Abstract: Information technology/cyber security for computer-related processes in which vulnerabilities are identified and, those vulnerabilities which are technology-related are automatically remediated by determining and executing network-based tasks. The most granular level of computer-related process assessment in made possible by reliance on a critical function/process taxonomy this is automatically generated and, as such, the present invention, identifies both technology and non-technology-related vulnerabilities.

Abstract: A system includes a programmable logic fabric core of an integrated circuit device and an IO interface communicatively coupled to the programmable logic fabric core. The IO interface includes multiple IO banks to implement a memory channel. Each IO bank includes a memory controller to control memory accesses of a memory device over the memory channel and multiple physical layer and IOs circuits to provide connections between the memory controller and the memory device. The respective memory controller may receive only a portion of data to be sent over the memory channel or multiple memory controllers may each receive all data to be sent over the memory channel.

Abstract: An integrated circuit includes a first input/output lane comprising first external terminals and first driver circuits. The first driver circuits exchange signals with a first external device through the first external terminals as part of a first external interface. The first input/output lane is part of a sub-bank in an input/output bank that implements at least a part of the first external interface. The integrated circuit includes a second input/output lane comprising second external terminals and second driver circuits. The second driver circuits exchange signals with a second external device through the second external terminals as part of a second external interface. The second input/output lane is part of the sub-bank in the input/output bank that implements at least a part of the second external interface.

Abstract: Information technology/cyber security for computer-related processes in which vulnerabilities are identified and, those vulnerabilities which are technology-related are automatically remediated by determining and executing network-based tasks. The most granular level of computer-related process assessment in made possible by reliance on a critical function/process taxonomy this is automatically generated and, as such, the present invention, identifies both technology and non-technology-related vulnerabilities.

Abstract: Information technology/cyber security for computer-related processes in which vulnerabilities are identified and, those vulnerabilities which are technology-related are automatically remediated by determining and executing network-based tasks. The most granular level of computer-related process assessment in made possible by reliance on a critical function/process taxonomy this is automatically generated and, as such, the present invention, identifies both technology and non-technology-related vulnerabilities.

Abstract: Information technology/cyber security for computer-related processes in which vulnerabilities are identified and, those vulnerabilities which are technology-related are automatically remediated by determining and executing network-based tasks. The most granular level of computer-related process assessment in made possible by reliance on a critical function/process taxonomy this is automatically generated and, as such, the present invention, identifies both technology and non-technology-related vulnerabilities.

Abstract: Dipeptidylpeptidase IV inhibitor (herein referred to as DPP-IV) that may be 98.5-100% pure is a high-dose drug capable of being directly compressed with a glitazone and specific excipients into sold form dosage forms, such as tablets and capsules having desired, hardness, disintegrating ability and acceptable dissolution characteristics. DPP-IV is not inherently compressible and thus presents formulation problems. Excipients used in the formulation enhance the flow and compaction properties of the drug and tableting mix. Optimal flow contributes to uniform die fill and weight control. The binder used ensures sufficient cohesive properties that allow DPP-IV to be compressed using the direct compression method. The tablets produced provide an acceptable in vitro dissolution profile.

Abstract: An architecture for a scalable computing machine built using configurable processing elements, such as FPGAs, is provided. The machine can enable implementation of large scale computing applications using a heterogeneous combination of hardware accelerators and embedded microprocessors spread across many FPGAs, all interconnected by a flexible communication network structure.

Abstract: The present invention is directed to solid, sustained-release, oral dosage form pharmaceutical compositions which contain therapeutic amounts of a pharmaceutically active agent, hydroxypropyl methyl cellulose and a non-ionic, hydrophilic polymer selected from the group consisting of hydroxyethyl cellulose having a number average molecular weight ranging from 90,000 to 1,300,000, hydroxypropyl cellulose having a number average molecular weight of 370,000 to 1,500,000, and poly(ethylene oxide) having a number average molecular weight ranging from 100,000 to 500,000.

Abstract: A high frequency, large bandwidth electronic device for transforming balanced/unbalanced electrical signals. In one embodiment, the device comprises an auto-transformer mounted on substrate interposed between the balanced and unbalanced port so as minimize parasitic losses. Bonded bi-filar wire is wound around the auto-transformer core which facilitates a low, balanced leakage inductance thereby further enhancing device bandwidth. A method of manufacturing the aforementioned electronic device is also disclosed.

Abstract: A tripeptide ligand of the formula -X-Y-Argininal is used to purify plasminogen activators.

Abstract: A method for purifying tPA or a plasminogen activator having an active site resembling that of tPA from an impure solution thereof which comprises contacting the impure solution with a solid support having bound thereto a tripeptide of the formula: -X-Y-argininal, wherein X and Y are amino acids selected from the group consisting of pro, phe, trp and tyr. The method is also used with a tripeptide of the formula: -phe-Y-argininal, wherein Y is selected from the group consisting of phe, pro, trp, tyr, val, ile and glu(PEA).